NCT06427447View on ClinicalTrials.gov

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

PHASE3RecruitingINTERVENTIONAL
Enrollment

770

Participants

Timeline

Start Date

August 6, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2029

Conditions
Pancreatic Cancer
Interventions
COMBINATION_PRODUCT

Adjuvant chemoradiotherapy

Upfront chemotherapy (gemcitabine plus capecitabine) followed chemoradiotherapy (radiotherapy with concurrent capecitabine)

DRUG

Adjuvant chemotherapy

Chemotherapy (gemcitabine plus capecitabine)

Trial Locations (1)

200433

RECRUITING

Huojun Zhang, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER